Conference · London, United Kingdom
European Pharmaceutical Market Access, Pricing and Reimbursement
Pharmaceuticals · Business consulting
Key numbers
- Editions on record
- 1first in 2016
About European Pharmaceutical Market Access, Pricing and Reimbursement
This year's agenda will have a strong focus on the future of pricing and reimbursement. Key topics include: -Updates on AMNOG and its implication on pricing and reimbursement -How biosimilars are affecting your pricing strategy -Capture on emerging markets’ regulatory framework to adapt your market access and PandR models -Orphan drugs using recent examples to highlight the impact on pricing -Cancer drug funding and budget cuts in the UK -Innovative solutions beyond the pill -Japanese, American, Nordic and Turkish regional update Key speakers in 2016: -Bertram Haussler, Chairman of the Board of Management, IGES -Simone Breitkopf, Head HEOR, Governmental and Public Affairs, Alcon -Ulf Staginnus, Head Market Access Oncology, Region Europe, Baxalta -Gordon Spencer, Regional Market Access Lead - EU and Canada, Shire International GmbH -Alexander Natz, Secretary General, EUCOPE -David Watson, Director of Pricing and PPRS, Association of the British Pharmaceutical Industry -Panos Kefalas, Head of Health Economics and Market Access, Cell and Gene Therapy Catapult and many more. Don't miss the workshop.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2016 | 10–11 Oct 2016 | Holiday Inn Kensington Forum Hotel London, United Kingdom | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is European Pharmaceutical Market Access, Pricing and Reimbursement?
The next dates haven't been confirmed. The last edition we have on record was 10–11 Oct 2016.
Where is it held?
The last edition we have was at Holiday Inn Kensington Forum Hotel, London, United Kingdom.